Ken Griffin Cortexyme, Inc. Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Cortexyme, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 1,600 shares of CRTX stock, worth $2,064. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,600Holding current value
$2,064% of portfolio
0.0%Shares
12 transactions
Others Institutions Holding CRTX
# of Institutions
48Shares Held
7.27MCall Options Held
103KPut Options Held
0-
Tang Capital Management LLC San Diego, CA2.95MShares$3.8 Million0.46% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.13MShares$1.46 Million0.0% of portfolio
-
Epiq Capital Group, LLC San Francisco, CA846KShares$1.09 Million0.43% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny520KShares$670,9290.0% of portfolio
-
Black Rock Inc. New York, NY332KShares$428,3900.0% of portfolio
About Cortexyme, Inc.
- Ticker CRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,150,800
- Market Cap $70.5M